Web Stats Provided By Google Analytics

Friday, April 25, 2014

FDA approves sylvant for multicentric castleman's disease

The U.S. Food and Drug Administration has approved Sylvant to treat patients with multicentric Castleman's disease , according to a news release issued by the agency today.

http://ift.tt/1lNns14
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)